Meet us at the BioProcess International European Summit in Amsterdam 24 – 25 April. Visit us at booth 17 or attend the presentation of our CEO, Menzo Havenga on Tuesday, 24 April at 12:30: ‘Difficult to Express Proteins: Novel Plasmid Technology to Significantly Increase Product Yield in CHO Cells’.
Yield is still an area that requires significant improvement for many promising recombinant proteins and antibodies. Novel vector technology enables rapid generation of stable, CHO cell lines able to provide at least 10-fold more product per cell. As part of the Cell Line Development & Engineering track Menzo will present a new case study of a biosimilar using this novel plasmid technology.
Link to event website.